Docetaxel-loaded Nanopharmaceutical CRLX301
Semantic Scholar uses AI to extract papers important to this topic.
Cerulean Pharma Inc.9s Dynamic Tumor Targeting™ Platform creates nanoparticle-drug conjugates (NDCs) designed to significantly… Expand 2526Background: CRLX301 is an investigational NDC with DOC covalently conjugated to a cyclodextrin-polyethylene glycol co-polymer… Expand Introduction. Nanoparticles (NPs) provide many advantages over small molecule drugs, such as greater solubility, increased… Expand Docetaxel is one of the most commonly prescribed anticancer agents. While efficacious, the therapeutic benefits of docetaxel are… Expand In this paper we examine the effect of rotation rate, mixing angle, and cohesion on the powder residence time and the content… Expand